1. Anderson RL, Panje WR, Gross CE. Optic nerve blindness following blunt forehead trauma. Ophthalmology. 1982; 89:445–455. 1982PMID:
7099563.
Article
2. Ansari MH. Blindness after facial fractures: a 19-year retrospective study. J Oral Maxillofac Surg. 2005; 63:229–237. PMID:
15690293.
Article
3. Beck RW, Cleary PA, Anderson MM Jr, Keltner JL, Shults WT, Kaufman DI, et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl J Med. 1992; 326:581–588. PMID:
1734247.
4. Bracken MB, Shepard MJ, Collins WF, Holford TR, Young W, Baskin DS, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med. 1990; 322:1405–1411. PMID:
2278545.
5. Dancey A, Perry M, Silva DC. Blindness after blunt facial trauma: are there any clinical clues to early recognition? J Trauma. 2005; 58:328–335. PMID:
15706196.
Article
6. Edwards P, Arango M, Balica L, Cottingham R, El-Sayed H, Farrell B, et al. Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months. Lancet. 2005; 365:1957–1959. PMID:
15936423.
7. Emanuelli E, Bignami M, Digilio E, Fusetti S, Volo T, Castelnuovo P. Post-traumatic optic neuropathy: our surgical and medical protocol. Eur Arch Otorhinolaryngol. 2015; 272:3301–3309. PMID:
25472815.
Article
8. Entezari M, Rajavi Z, Sedighi N, Daftarian N, Sanagoo M. High-dose intravenous methylprednisolone in recent traumatic optic neuropathy; a randomized double-masked placebo-controlled clinical trial. Graefes Arch Clin Exp Ophthalmol. 2007; 245:1267–1271. PMID:
17265030.
Article
9. Ghezzi P, Brines M. Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death Differ. 2004; 11(Suppl 1):S37–S44. PMID:
15243580.
Article
10. Gross CE, DeKock JR, Panje WR, Hershkowitz N, Newman J. Evidence for orbital deformation that may contribute to monocular blindness following minor frontal head trauma. J Neurosurg. 1981; 55:963–966. PMID:
7299470.
Article
11. Hughes B. Indirect injury of the optic nerves and chiasma. Bull Johns Hopkins Hosp. 1962; 111:98–126. PMID:
14449787.
12. Kanamori A, Nakamura M, Yamada Y, Negi A. Longitudinal study of retinal nerve fiber layer thickness and ganglion cell complex in traumatic optic neuropathy. Arch Ophthalmol. 2012; 130:1067–1069. PMID:
22893082.
Article
13. Kashkouli MB, Pakdel F, Sanjari MS, Haghighi A, Nojomi M, Homaee MH, et al. Erythropoietin: a novel treatment for traumatic optic neuropathy-a pilot study. Graefes Arch Clin Exp Ophthalmol. 2011; 249:731–736. PMID:
20890611.
Article
14. Kashkouli MB, Yousefi S, Nojomi M, Sanjari MS, Pakdel F, Entezari M, et al. Traumatic optic neuropathy treatment trial (TONTT): open label, phase 3, multicenter, semi-experimental trial. Graefes Arch Clin Exp Ophthalmol. 2018; 256:209–218. PMID:
28986670.
Article
15. Lai IL, Liao HT, Chen CT. Risk factors analysis for the outcome of indirect traumatic optic neuropathy with steroid pulse therapy. Ann Plast Surg. 2016; 76(Suppl 1):S60–S67. PMID:
26808764.
Article
16. Levin LA, Beck RW, Joseph MP, Seiff S, Kraker R. The treatment of traumatic optic neuropathy: the International Optic Nerve Trauma Study. Ophthalmology. 1999; 106:1268–1277. PMID:
10406604.
17. Lew H, Lee SY, Jang JW, Kim HY, Kang SJ, Kim SJ. The effects of high-dose corticosteroid therapy on optic nerve head blood flow in experimental traumatic optic neuropathy. Ophthalmic Res. 1999; 31:463–470. PMID:
10474076.
Article
18. Mackiewicz J, Tomaszewska J, Jasielska M. Optic nerve avulsion after blunt ocular trauma - Case report. Ann Agric Environ Med. 2016; 23:382–383. PMID:
27294653.
Article
19. Magarakis M, Mundinger GS, Kelamis JA, Dorafshar AH, Bojovic B, Rodriguez ED. Ocular injury, visual impairment, and blindness associated with facial fractures: a systematic literature review. Plast Reconstr Surg. 2012; 129:227–233. PMID:
21915081.
20. Sarkies N. Traumatic optic neuropathy. Eye (Lond). 2004; 18:1122–1125. PMID:
15534597.
Article
21. Sawhney R, Kochhar S, Gupta R, Jain R, Sood S. Traumatic optic nerve avulsion: role of ultrasonography. Eye (Lond). 2003; 17:667–670. PMID:
12855988.
Article
22. Seiff SR. High dose corticosteroids for treatment of vision loss due to indirect injury to the optic nerve. Ophthalmic Surg. 1990; 21:389–395. PMID:
2381671.
Article
23. Sosin M, De La Cruz C, Mundinger GS, Saadat SY, Nam AJ, Manson PN, et al. Treatment outcomes following traumatic optic neuropathy. Plast Reconstr Surg. 2016; 137:231–238. PMID:
26710028.
Article
24. Spoor TC, Hartel WC, Lensink DB, Wilkinson MJ. Treatment of traumatic optic neuropathy with corticosteroids. Am J Ophthalmol. 1990; 110:665–669. PMID:
2248332.
Article
25. Steinsapir KD, Goldberg RA. Traumatic optic neuropathy. Surv Ophthalmol. 1994; 38:487–518. PMID:
8066541.
Article
26. Xie D, Yu H, Ju J, Zhang L. The outcome of endoscopic optic nerve decompression for bilateral traumatic optic neuropathy. J Craniofac Surg. 2017; 28:1024–1026. PMID:
28590394.
Article
27. Yu-Wai-Man P. Traumatic optic neuropathy-Clinical features and management issues. Taiwan J Ophthalmol. 2015; 5:3–8. PMID:
26052483.
Article
28. Yu-Wai-Man P, Griffiths PG. Surgery for traumatic optic neuropathy. Cochrane Database Syst Rev. 2005; CD005024. PMID:
16235388.
Article
29. Yu-Wai-Man P, Griffiths PG. Steroids for traumatic optic neuropathy. Cochrane Database Syst Rev. 2007; CD006032. PMID:
17943877.
Article
30. Yu-Wai-Man P, Griffiths PG. Steroids for traumatic optic neuropathy. Cochrane Database Syst Rev. 2011; CD006032. PMID:
21249673.
Article
31. Yu-Wai-Man P, Griffiths PG. Steroids for traumatic optic neuropathy. Cochrane Database Syst Rev. 2013; CD006032. PMID:
23771729.
Article
32. Yu-Wai-Man P, Griffiths PG. Surgery for traumatic optic neuropathy. Cochrane Database Syst Rev. 2013; 6:CD005024. PMID:
23780732.
Article